Sébastien Robitaille serves as DBV’s Chief Transformation Officer and Deputy Chief Financial Officer, responsible for leading the Company’s operational transformation from a development-stage biotechnology company to a potential commercial organization. He oversees Finance, Information Systems at Group level and Human Resources in France, and is a member of the Executive Committee. Mr. Robitaille joined DBV in 2015 as Senior Vice President, Group Controller & Information Systems and subsequently was named Deputy Chief Financial Officer. Prior to DBV, he worked at Ipsen for 15 years where he held various roles of increasing responsibility and participated in the company’s IPO. Mr. Robitaille has extensive experience in the pharmaceutical industry and deep knowledge of performance management, forecasting and business modelling, transformation programs and implementation of strategic information systems. He holds a Bachelor’s Degree in Business Administration-Finance from Paris School of Business.